What this class covers
ANZSIC class 1841 classifies Australian businesses engaged in manufacturing pharmaceutical and medicinal products specifically for human use. This includes production from both natural sources (such as plant extracts) and synthetic chemical compounds. The class encompasses a wide range of therapeutic substances designed for human medical treatment, prevention, and diagnosis.
Businesses in this classification operate under Australia's strict therapeutic goods regulations and typically require specialized manufacturing facilities. Examples include companies producing prescription medications, over-the-counter drugs, vaccines, diagnostic testing agents, and medicinal preparations derived from herbal sources. These operations range from large-scale pharmaceutical manufacturing plants to specialized producers of specific medicinal compounds.
Typical businesses in this class include manufacturers of antibiotic medications, vitamin supplements, hormonal treatments, blood products, and diagnostic substances used in medical testing. The classification applies regardless of production scale, covering everything from major pharmaceutical companies to smaller specialty manufacturers producing niche medicinal products for the Australian market.
Primary activities in plain English
Businesses classified under ANZSIC 1841 typically engage in one or more of the following activities:
- Producing pharmaceutical drugs including antibiotics, analgesics, and other prescription medications
- Manufacturing medicinal preparations such as vitamins, hormones, and herbal medicines
- Creating vaccines and immunological products for human disease prevention
- Producing diagnostic substances including antibodies, antigens, and chemical testing agents
- Manufacturing medicinal delivery forms like capsules, ointments, ampoules, and vials
- Developing biotechnological pharmaceutical products using advanced manufacturing techniques
Exclusions and nearby codes
Several related activities are specifically excluded from ANZSIC 1841 and classified elsewhere:
- Manufacturing of sanitary paper products (nappies, sanitary napkins) falls under ANZSIC 1524
- Production of basic organic chemicals including ether is classified in ANZSIC 1812
- Manufacturing medicinal gases is included in ANZSIC 1811
- Veterinary pharmaceutical manufacturing is separately classified under ANZSIC 1842
- Contract packaging and labelling services fall under ANZSIC 7320
- Manufacturing medical and diagnostic equipment is classified in ANZSIC 2412
Practical guidance
Businesses operating in this classification should be aware of several practical considerations. The Australian Business Number (ABN) registration requires accurate ANZSIC classification, which affects how your business is categorized for statistical and regulatory purposes. This classification may influence your Business Industry Code (BIC) for tax reporting requirements.
Workers' compensation insurance premiums may be affected by this classification, as pharmaceutical manufacturing typically involves specific workplace health and safety considerations. Businesses in this sector should consult with their state-based workers' compensation authority for appropriate classification.
This industry is heavily regulated by the Therapeutic Goods Administration (TGA), which oversees manufacturing standards, product registration, and quality control requirements. Businesses may need to comply with Good Manufacturing Practice (GMP) standards and maintain appropriate licenses for handling controlled substances.
When completing business activity statements (BAS) and tax returns, ensure consistency between your ANZSIC classification and the activities you report. Industry-specific grants or assistance programs may sometimes reference ANZSIC classifications, though eligibility depends on specific program criteria.